We are live on ! Find out more
CTNM

Contineum Therapeutics
CTNM

70 hedge funds and large institutions have $55.4M invested in Contineum Therapeutics in 2025 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 12 increasing their positions, 22 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 20

11% more funds holding

Funds holding: 63 → 70 (+7)

7.36% less ownership

Funds ownership: 79.89% → 72.53% (-7.4%)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

45% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 22

48% less capital invested

Capital invested by funds: $107M → $55.4M (-$51.3M)

Holders
70
Holders Change
+7
Holders Change %
+11.11%
% of All Funds
0.92%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.05%
New
27
Increased
12
Reduced
22
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$1.69M
2
Millennium Management
Millennium Management
New York
+$575K
3
Franklin Resources
Franklin Resources
California
+$533K
4
MAM
Monaco Asset Management
Monaco
+$326K
5
Two Sigma Investments
Two Sigma Investments
New York
+$265K

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$3.22M
2
BlackRock
BlackRock
New York
-$1.96M
3
VVM
Versant Venture Management
California
-$1.63M
4
SVCM
Saturn V Capital Management
Texas
-$1.05M
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$529K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$242K +$203K +46,701 +328%
SWA
27
Strategies Wealth Advisors
Michigan
$199K +$109K +25,000 +100%
Two Sigma Advisers
28
Two Sigma Advisers
New York
$172K +$188K +43,200 New
RC
29
RBF Capital
California
$159K +$174K +40,000 New
YIH
30
Y-Intercept (HK)
Hong Kong
$140K +$153K +35,156 New
State Street
31
State Street
Massachusetts
$115K -$426K -97,964 -77%
Marshall Wace
32
Marshall Wace
United Kingdom
$114K -$10.4K -2,399 -8%
IFG
33
Independent Financial Group
California
$107K +$117K +27,021 New
Charles Schwab
34
Charles Schwab
California
$103K -$109K -25,163 -49%
Northern Trust
35
Northern Trust
Illinois
$99.9K -$254K -58,457 -70%
AQR Capital Management
36
AQR Capital Management
Connecticut
$99.9K +$109K +25,156 New
Jane Street
37
Jane Street
New York
$80.7K +$88.3K +20,321 New
Susquehanna International Group
38
Susquehanna International Group
Pennsylvania
$79.9K +$29.9K +6,874 +52%
JG
39
Jain Global
New York
$77.8K +$85.1K +19,590 New
BCM
40
Bridgeway Capital Management
Texas
$76.2K +$83.4K +19,200 New
Jacobs Levy Equity Management
41
Jacobs Levy Equity Management
New Jersey
$68.5K +$74.9K +17,245 New
Citadel Advisors
42
Citadel Advisors
Florida
$65.5K +$71.7K +16,489 New
Renaissance Technologies
43
Renaissance Technologies
New York
$57.2K +$62.6K +14,404 New
PCM
44
Prelude Capital Management
New York
$55.3K +$60.5K +13,920 New
MG
45
Marex Group
$45.3K +$49.5K +11,400 New
Qube Research & Technologies (QRT)
46
Qube Research & Technologies (QRT)
United Kingdom
$43.4K +$47.5K +10,924 New
UBS Group
47
UBS Group
Switzerland
$30.4K -$24.5K -5,629 -42%
Wells Fargo
48
Wells Fargo
California
$29.9K -$14.5K -3,334 -31%
TRCT
49
Tower Research Capital (TRC)
New York
$29.6K +$26.5K +6,097 +449%
Acadian Asset Management
50
Acadian Asset Management
Massachusetts
$21K +$23.5K +5,400 New
1
2
3 4

CTNM Hedge Fund Activity: Q2 2025 in Review

70 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Contineum Therapeutics (CTNM) for Q2 2025, worth a combined $55.4M — down 48% from $107M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new CTNM positions and 20 closed out — a net gain of 7 holders — while 12 added to existing stakes and 22 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $1.69M. The largest seller was Perceptive Advisors, cutting an estimated $3.22M.

  • 70 institutional investors held Contineum Therapeutics (CTNM) as of Q2 2025, up from 63 in Q1 2025.
  • Funds reported $55.4M of Contineum Therapeutics stock for Q2 2025, down 48% quarter-over-quarter.
  • 27 funds opened new Contineum Therapeutics positions in Q2 2025 and 20 closed out, a net change of +7 holders.
  • The largest Contineum Therapeutics buyer in Q2 2025 was Point72 Asset Management, an estimated $1.69M added.
  • The largest Contineum Therapeutics seller in Q2 2025 was Perceptive Advisors, an estimated $3.22M sold.

Based on aggregated 13F filings for Q2 2025.